Brief: XSpray Pharma Board Member Anders Bladh Acquires Shares From CEO
March 14 (Reuters) - Xspray Pharma AB (publ)
XSPRAY.ST :
* SAID ON MONDAY BOARD MEMBER IN XSPRAY PHARMA, ANDERS
BLADH,
ACQUIRES 30,000 CO SHARES FROM CEO VIA HIS COMPANY RIBBSKOTTET
AB
* TRANSACTION WAS COMPLETED OUTSIDE STOCK MARKET TRADING AT
A
SHARE PRICE OF SEK 72.00
* RIBBSKOTTET INCREASES ITS OWNERSHIP TO 2,480,000 SHARES
Source text for Eikon: urn:newsml:reuters.com:*:nMFN5HdRZ5
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003